DMEMEDS shared post via Reuters: Pfizer to apply for early U.S. approval of breast cancer drug

(Reuters) - Pfizer Inc, which is in the process of trying to acquire British rival AstraZeneca for more than $100 billion, on Friday said it planned to seek U.S. approval for palbociclib, its experimental drug for advanced breast cancer, in the third quarter. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/teKcyKpZqX4/story01.htm

Read More